Brief Research Report
Published on 27 Mar 2025
Basophil activation test and lymphocyte transformation test in cefuroxime-induced anaphylactic reactions
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2025.1532775
Type at least 3 characters
59 articles
Articles
Original Research
Accepted on 18 Mar 2025
Fire ant venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2025.1570123
Brief Research Report
Published on 07 Jan 2025
Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1502285
- 771 views
Original Research
Published on 24 Dec 2024
Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1512875
- 699 views
Editorial
Published on 16 Dec 2024
Editorial: Drug allergy in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1530907
- 403 views
Brief Research Report
Published on 09 Dec 2024
Demographic characteristics associated with a penicillin allergy label during pregnancy
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1511392
- 614 views
- 1 citation
Case Report
Published on 01 Nov 2024
Case Report: Anaphylaxis caused by traditional Chinese medicine in a patient with pollinosis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1470638
- 746 views
Mini Review
Published on 18 Oct 2024
When allergies have no name: is idiopathic anaphylaxis driven by co-factors?
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1468945
- 1,832 views
Case Report
Published on 18 Oct 2024
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1401187
- 1,783 views
Case Report
Published on 11 Oct 2024
A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1472320
- 1,302 views
Original Research
Published on 30 Aug 2024
Single center experience with more than 600 drug desensitization in Colombia
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1460326
- 846 views
Mini Review
Published on 26 Aug 2024
Rare causes of pediatric anaphylaxis due to obscure allergens
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1456100
- 1,534 views
- 1 citation
Original Research
Published on 06 Aug 2024
Drug fever—an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1361403
- 931 views
Case Report
Published on 11 Mar 2024
Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1366922
- 2,128 views
Mini Review
Published on 07 Feb 2024
Recent findings on drug hypersensitivity in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1330517
- 3,182 views
- 1 citation
Brief Research Report
Published on 16 Jan 2024
Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1331036
- 1,381 views
- 1 citation